ELK3 and breast cancer: Next, we transfected MDA-MB 231 cells with the candidate miRNAs and found that only miR-200a suppressed the endogenous ELK3 mRNA level significantly (Figure 3A), suggesting that miR-200a might be the main factor that determines the amount of ELK3 mRNA in breast cancer cells.